Wenying Jiang

机构：Shandong University of Traditional Chinese Medicine · ORCID：0000-0002-1438-6675

发表论文 12 篇 · 总被引 60 次 · h-index 3

代表论文

• Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer (2022 · International Immunopharmacology · 被引 32)
• Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic SIRT1/PGC-1α pathway (2024 · European Journal of Pharmacology · 被引 13)
• Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics (2023 · Cancer Medicine · 被引 6)
• Diosgenin Ameliorates Insulin Resistance in High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease Rats via the Adiponectin/ADIPOR1/APPL1 Pathway (2025 · Journal of Agricultural and Food Chemistry · 被引 3)
• Malignant features related PRDX1 associated with osimertinib sensitivity of EGFR-mutant lung adenocarcinoma (2025 · International Journal of Medical Sciences · 被引 2)
• Prognostic value of FDX1, the cuprotosis key gene, and its prediction models across imaging modalities and histology (2024 · BMC Cancer · 被引 2)